XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Feb. 28, 2022
Dec. 10, 2021
Dec. 10, 2021
Mar. 31, 2022
Dec. 31, 2018
Dec. 31, 2016
Dec. 31, 2021
Loss Contingencies [Line Items]              
Finite-lived intangible asset, useful life       5 years      
Purchase obligation       $ 1,300,000     $ 511,000
Stockholders' Equity, Reverse Stock Split   5-for-1 reverse stock split          
Maximum [Member]              
Loss Contingencies [Line Items]              
Proceeds from issuance of common stock       150,000,000      
Harborside [Member]              
Loss Contingencies [Line Items]              
Stock Issued During Period, Shares, Reverse Stock Splits   1,000,000          
Stock Issued During Period, Shares, Stock Splits   200,000          
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs   $ 1,000,000          
Incurred damage related aforementioned stock   $ 75,000 $ 75,000        
Harborside [Member] | Maximum [Member]              
Loss Contingencies [Line Items]              
Loss Contingency, Damages Sought, Value     33,020,000        
Harborside [Member] | Minimum [Member]              
Loss Contingencies [Line Items]              
Loss Contingency, Damages Sought, Value     5,020,000        
Conversion Labs Rx Business [Member]              
Loss Contingencies [Line Items]              
Stock Issued During Period, Shares, Stock Splits   200,000          
Conversion Labs Rx Business [Member] | Maximum [Member]              
Loss Contingencies [Line Items]              
Stock Issued During Period, Shares, Stock Splits   1,000,000          
Subscription Agreement [Member]              
Loss Contingencies [Line Items]              
Accounts payable and accrued expenses       $ 0     $ 0
Pilaris Laboratories LLC [Member]              
Loss Contingencies [Line Items]              
Finite-lived intangible asset, useful life           10 years  
Percentage of net income           10.00%  
Share based compensation arrangement by share based payment award, expiration period         10 years    
Pilaris Laboratories LLC [Member] | CVLB PR [Member]              
Loss Contingencies [Line Items]              
Intercompany agreements, description           As consideration for granting Conversion Labs PR this license, Pilaris will receive on quarterly basis, 10% of the net income collected by the licensed products based on the following formula: Net Income = total income – cost of goods sold – advertising and operating expenses directly related to the marketing of the licensed products  
MALPHABET LLC [Member]              
Loss Contingencies [Line Items]              
Intercompany agreements, description       The Company shall pay Alphabet a royalty equal to 13% of Gross Receipts (as defined in the Agreement) realized from the sales of Licensed Products. No amounts were earned or owed as of March 31, 2022      
Percentage for royalty         13.00%    
Share based compensation arrangement by share based payment award, options, grants in period, gross         20,000    
Share based compensation arrangements by share based payment award, options, exercises in period, weighted average exercise price         $ 2.50    
MALPHABET LLC [Member] | Common Stock One [Member]              
Loss Contingencies [Line Items]              
Share based compensation arrangement by share based payment award, options, grants in period, gross         20,000    
Share based compensation arrangements by share based payment award, options, exercises in period, weighted average exercise price         $ 2.50    
Proceeds from issuance of common stock         $ 7,500,000    
MALPHABET LLC [Member] | Common Stock Two [Member]              
Loss Contingencies [Line Items]              
Share based compensation arrangement by share based payment award, options, grants in period, gross         20,000    
Share based compensation arrangements by share based payment award, options, exercises in period, weighted average exercise price         $ 2.50    
Proceeds from issuance of common stock         $ 10,000,000    
MALPHABET LLC [Member] | Common Stock Three [Member]              
Loss Contingencies [Line Items]              
Share based compensation arrangement by share based payment award, options, grants in period, gross         40,000    
Share based compensation arrangements by share based payment award, options, exercises in period, weighted average exercise price         $ 3.75    
Proceeds from issuance of common stock         $ 20,000,000    
Conversion Labs Rx Business [Member] | Harborside [Member]              
Loss Contingencies [Line Items]              
Stock Issued During Period, Shares, Reverse Stock Splits   10,000,000          
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs   $ 5,000,000          
Conversion Labs Rx Business [Member] | Harborside [Member] | Maximum [Member]              
Loss Contingencies [Line Items]              
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs   $ 5,000,000          
Conversion Labs Rx [Member]              
Loss Contingencies [Line Items]              
Loss contingency breach of contract amount     $ 273,859        
Blair L L C [Member]              
Loss Contingencies [Line Items]              
Loss contingency breach of contract amount $ 1,000,000